Here, we investigated the effect of 1-kestose supplementation on glucose metabolism, i.e., fasting insulin level and glucose intolerance, in HFD-fed rats as a preliminary study, and then conducted a clinical trial to examine the feasibility of 1-kestose to improve insulin resistance in obesity-prone participants. This evidence concerns the gene INS and obesity disorder.